Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway

CONTEXT: Shenmai Injection (SMI) is usually used to treat atherosclerotic coronary heart disease and viral myocarditis in China. However, the effect of SMI on multidrug resistance has not been reported. OBJECTIVE: To investigate the reversal effect of SMI in adriamycin (ADR) resistant breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Zhang, Chengda, Chen, Jiaoting, Zhang, Sheng, Pan, Guixuan, Xin, Yanfei, Lin, Lin, You, Zhenqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170370/
https://www.ncbi.nlm.nih.gov/pubmed/32251615
http://dx.doi.org/10.1080/13880209.2020.1742167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170370/
https://www.ncbi.nlm.nih.gov/pubmed/32251615
http://dx.doi.org/10.1080/13880209.2020.1742167

Ejemplares similares